iSpecimen Inc (ISPC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, iSpecimen Inc (ISPC) has a cash flow conversion efficiency ratio of -0.297x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-916.92K) by net assets ($3.09 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
iSpecimen Inc - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how iSpecimen Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read iSpecimen Inc (ISPC) total liabilities for a breakdown of total debt and financial obligations.
iSpecimen Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of iSpecimen Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
KD Corporation
KQ:044180
|
-0.058x |
|
Property Franchise Group PLC
LSE:TPFG
|
0.089x |
|
Shuttle Pharmaceuticals Inc
NASDAQ:SHPH
|
-0.432x |
|
Marston’s PLC
LSE:MARS
|
0.097x |
|
Octopus Renewables Infra Trust
LSE:ORIT
|
0.039x |
|
Voxtur Analytics Corp
V:VXTR
|
0.133x |
|
Tiphone Mobile Indonesia Tbk
JK:TELE
|
0.000x |
|
Avrupa Minerals Ltd
V:AVU
|
-0.168x |
Annual Cash Flow Conversion Efficiency for iSpecimen Inc (2018–2025)
The table below shows the annual cash flow conversion efficiency of iSpecimen Inc from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see ISPC company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $3.09 Million | $-4.24 Million | -1.373x | +44.98% |
| 2024-12-31 | $3.31 Million | $-8.26 Million | -2.496x | -318.63% |
| 2023-12-31 | $9.74 Million | $-5.81 Million | -0.596x | -108.13% |
| 2022-12-31 | $20.31 Million | $-5.82 Million | -0.286x | +20.01% |
| 2021-12-31 | $29.79 Million | $-10.67 Million | -0.358x | -3487.29% |
| 2020-12-31 | $-27.28 Million | $-288.38K | 0.011x | -91.04% |
| 2019-12-31 | $-22.72 Million | $-2.68 Million | 0.118x | -18.96% |
| 2018-12-31 | $-18.42 Million | $-2.68 Million | 0.146x | -- |
About iSpecimen Inc
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers worldwide. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. Its marketplace offers human biospecim… Read more